Steven Cohen’s Rocket Pharmaceuticals RCKT Stock Holding History

Steven Cohen’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29M	Sell	670,527 -341,599	-34%	-$1.14M	﹤0.01%	2299
2026 Q1	$3.62M	Buy	1,012,126 +504,217	+99%	+$2M	﹤0.01%	1915
2025 Q4	$1.78M	Buy	+507,909	New	+$1.74M	﹤0.01%	2548
2025 Q1	–	Sell	-1,569,823	Closed	-$19.7M	–	2449
2024 Q4	$19.7M	Buy	1,569,823 +1,521,727	+3,164%	+$22.9M	0.04%	459
2024 Q3	$888K	Buy	+48,096	New	+$985K	﹤0.01%	1464
2018 Q1	–	Sell	-133,996	Closed	-$1.4M	–	1089
2017 Q4	$1.4M	Sell	133,996 -24,870	-16%	-$247K	0.01%	774
2017 Q3	$1.13M	Buy	+158,866	New	+$726K	0.01%	729
2016 Q4	–	Sell	-220,000	Closed	-$8.34M	–	814
2016 Q3	$8.34M	Buy	220,000 +4,000	+2%	+$126K	0.06%	313
2016 Q2	$6.43M	Sell	216,000 -34,851	-14%	-$1.23M	0.04%	378
2016 Q1	$7.42M	Sell	250,851 -36,174	-13%	-$1.09M	0.06%	347
2015 Q4	$13M	Sell	287,025 -14,202	-5%	-$619K	0.11%	222
2015 Q3	$11.3M	Buy	+301,227	New	+$13.8M	0.09%	279

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Steven Cohen's RCKT Position: Q2 2026 in Review

Steven Cohen reduced its Rocket Pharmaceuticals (RCKT) stake by 34% in Q2 2026, selling an estimated $1.14M and leaving 670,527 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

Steven Cohen first reported a position in RCKT in Q3 2015 and has held it in 12 quarters since. The position peaked at $19.7M in Q4 2024. 178 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Steven Cohen held 670,527 shares of Rocket Pharmaceuticals worth $2.29M as of Q2 2026.
Steven Cohen sold 341,599 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.14M.
Rocket Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2299 holding.
Steven Cohen first reported a position in Rocket Pharmaceuticals in Q3 2015 and has held it in 12 quarters since.
Steven Cohen's Rocket Pharmaceuticals position peaked at $19.7M in Q4 2024.
178 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.